Cancers

Jun 14, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Interim Data Gives Hope to Myelofibrosis Patients Facing Sup-Optimal Results from Ruxolitinib Alone

Peter Langmuir, MD, Group Vice President, Oncology Targeted…
May 28, 2021| Posted in: Cancers, News, Treatment

FDA Approves Oral Therapy for Advanced Cholangiocarcinoma

The U.S. Food and Drug Administration (FDA) has…
May 28, 2021| Posted in: Cancers, Lung Diseases, Regulations, Treatment

FDA Approves Drug for Lung Cancer Mutation Once Considered “Undruggable”

The U.S. Food and Drug Administration (FDA) has…
May 19, 2021| Posted in: Cancers, Skin Conditions, Treatment

Two Things Physicians Ought to Know about CTCL

Lauren Pinter-Brown, MD, Clinical Professor of Hematology/Oncology, University…
May 12, 2021| Posted in: Cancers, Diagnosis, Skin Conditions, Treatment

How Cutaneous T-cell Lymphoma is Diagnosed and Treated

Lauren Pinter-Brown, MD, Clinical Professor of Hematology/Oncology, University…
Apr 22, 2021| Posted in: Cancers, Diagnosis, Endocrine Disorders, Metabolic Disorders

Acromegaly and the Dentist

Susan Samson, MD, PhD, of the Mayo Clinic…
Apr 19, 2021| Posted in: Cancers, Diagnosis, Expert Perspectives

Overview of Follicular Lymphoma and Marginal Zone Lymphoma

Owen A. O’Connor, Chief Scientific Officer at TG…
Apr 15, 2021| Posted in: Cancers, Drug Development, Treatment

Umbralisib: Mechanism of Action and Its Efficacy to Treat Follicular or Marginal Zone Lymphoma

Owen A. O’Connor, Chief Scientific Officer at TG…

Tenosynovial Giant Cell Tumor (TGCT)

Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor involving the joint synovium, bursae, and tendon sheath. These rare tumors are sometimes referred to as giant cell tumor of the tendon sheath (GCT-TS) and/or pigmented villonodular synovitis (PVNS).

Neuroendocrine Tumors (NETs) Research Highlights: CME Program

Edward M Wolin, MD from the Tisch Cancer Institute at Mount Sinai and Icahn School of Medicine at Mount Sinai, highlights the latest information about NETs and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with these rare diseases.

Cutaneous T-Cell Lymphoma Learning Center

Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders. It is a rare group of malignancies, with an incidence of 6.4 cases per 1 million people.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

CME Program: Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium 2020

Barbara K. Burton, MD highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with these rare diseases.

Cancers

Topics